Recursion Pharmaceuticals Inc (RXRX) is higher by Thursday morning, with the stock climbing 1.63% in pre-market trading to 11.25. RXRX's short-term technical score of 53 indicates that the stock has traded more bullishly over the last month than 53% of stocks on the market. In the Biotechnology industry, which ranks 98 out of 146 industries, RXRX ranks higher than 65% of stocks. Recursion Pharmaceuticals Inc has fallen 15.82% over the past month, closing at $15.00 on February 22. During this period of time, the stock fell as low as $10.37 and as high as $15.74. RXRX has an average analyst recommendation of Buy. The company has an average price target of $13.00.
RXRX has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on RXRX!